A similar effect of fibrinogen on efficacy and safety of tenecteplase <i>versus</i> alteplase in acute ischemic cerebrovascular events (TRACE II) trial
The results of the study suggest that the efficacy and safety of tenecteplase in treated AIS patients within 4.5 h are comparable to those of alteplase, regardless of plasma fibrinogen levels.
Authors
- Lamia Mbarek (ORCID: https://orcid.org/0000-0003-1800-0108)
- Yuesong Pan (ORCID: https://orcid.org/0000-0003-3082-6789)
- Aoming Jin (ORCID: https://orcid.org/0000-0002-7221-5444)
- Yongjun Wang (ORCID: https://orcid.org/0000-0002-9976-2341)
- Shuya Li (ORCID: https://orcid.org/0000-0002-7263-0365)
- Hao Li (ORCID: https://orcid.org/0000-0002-8462-0383)
- Meng Xia (ORCID: https://orcid.org/0000-0002-9711-6215)
- Yunyun Xiong
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Tian Tan Hospital (CN)
- Beijing Academy of Artificial Intelligence (CN)
Publication Details
- Journal
- Journal of Translational Internal Medicine
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1515/jtim-2025-0010
- Citations
- 1
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences
- National Science and Technology Major Project